Back to Search
PAULA ROY-BURMAN, M.D.
M.D.
Hospitalist Physician
NPI: 1750524203IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
265851(NY)
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
265851(NY)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
UNIVERSITY OF SOUTHERN CALIFORNIA KECK SCHOOL OF MEDICINE
Class of 2009
Research & Publications (20)
PTEN knockout prostate cancer as a model for experimental immunotherapy.
PMID 19010487·J Urol·2009
7-preclinical
Identification of a novel common proviral integration site, flit-1, in feline leukemia virus induced thymic lymphoma.
PMID 19203775·Virology·2009
7-preclinical
Activation of beta-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration.
PMID 18991257·Prostate·2009
7-preclinical
Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium.
PMID 19033462·Proc Natl Acad Sci U S A·2008
7-preclinical
A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer.
PMID 18172312·Cancer Res·2008
7-preclinical
Inactivation of Apc in the mouse prostate causes prostate carcinoma.
PMID 17363566·Cancer Res·2007
7-preclinical
Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence.
PMID 17671224·Cancer Res·2007
7-preclinical
Tumor progression and metastasis from genetic to microenvironmental determinants: a workshop of the tumor progression and metastasis NIH study section in honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC.
PMID 17224636·Cancer Biol Ther·2006
7-preclinical
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer.
PMID 16912162·Cancer Res·2006
7-preclinical
Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways.
PMID 16618753·Cancer Res·2006
8-other
Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.
PMID 16489020·Cancer Res·2006
7-preclinical
Increased expression of osteopontin contributes to the progression of prostate cancer.
PMID 16424021·Cancer Res·2006
7-preclinical
Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells.
PMID 15994952·Cancer Res·2005
8-other
In vivo expression of GFP transgene delivered via a replicating feline leukemia virus.
PMID 16143471·Vet Microbiol·2005
7-preclinical
EphB4 expression and biological significance in prostate cancer.
PMID 15930280·Cancer Res·2005
7-preclinical
Genetically defined mouse models that mimic natural aspects of human prostate cancer development.
PMID 15163300·Endocr Relat Cancer·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 525 E 68TH ST # 331
NEW YORK, NY 10065 - Phone
- (212) 746-4071
Quick Facts
- NPI
- 1750524203
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile